Used in nuclear medicine for diagnostic imaging of somatostatin receptor-positive tumors, particularly neuroendocrine tumors. It is radiolabeled with isotopes like indium-111 or gallium-68 for detection via SPECT or PET imaging. Helps in tumor localization, staging, and monitoring response to therapy. Also supports selection of patients for peptide receptor radionuclide therapy (PRRT).